Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration
Titel:
Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration
Auteur:
Printz, Marie A. Sugarman, Barry J. Paladini, Rudolph D. Jorge, Michael C. Wang, Yan Kang, David W. Maneval, Daniel C. LaBarre, Michael J.